関連する実験動画
Updated: Jun 29, 2026

11:33
Isolation and Kv Channel Recordings in Murine Atrial and Ventricular Cardiomyocytes
Published on: March 12, 2013
複合変異:重度の長QT症候群の一般的な原因である
Peter Westenskow1, Igor Splawski, Katherine W Timothy
1Department of Physiology, University of Utah, 95 South 2000 East, Salt Lake City, UT 84112-5000, USA.
Circulation
|March 31, 2004
まとめ
LQTS遺伝子の複合変異は,これまで考えられていたよりも一般的です. これらの遺伝的変異は,罹患した個人の心臓病および突然死のリスクを大幅に増加させます.
科学分野:
- 心臓病学 心臓病学
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- ロングQT症候群 (Long QT syndrome,LQTS) は,不律性による突然心臓死のリスクを増やす遺伝疾患です.
- LQTSにおけるフェノタイプの変動は,家族内でも顕著であり,根本的なメカニズムは不明のままである.
研究 の 目的:
- LQTSに関連する遺伝子における複合変異の発生率と影響を調査する.
- 複合変異がLQTSの重症度とフェノタイプの変化に与える影響を理解する.
主な方法:
- 252人のLQTS受験者におけるKVLQT1,HERG,KCNE1,KCNE2,SCN5Aの遺伝子解析.
- 2マイクロエレクトロドの電圧クランプ 変種イオンチャネル機能を特徴付けるために,Xenopusの卵細胞における電気生理学.
主要な成果:
- 複合変異は,LQTS試験患者の7.9%で検出されました.
- 複合変異を有する個体は,単一の変異または変異のない個体と比較して,QTc間隔を大幅に延長し,心臓発作の頻度 (100%対72%) を高く,心臓発作の確率を3.5倍増加させた.
- 電気生理学的研究は,化合物変異がI(Ks) チャンネル機能の低下につながることを確認しました.
結論:
- LQTSに関連した化合物変異は,予想以上に流行しており,重度の臨床現象型に関連しています.
- 複合変異を有する個人を特定することは,心律乱症のリスクの高まりを軽減するために,調整された管理戦略にとって極めて重要です.
関連する概念動画
Mutations
Overview
Mutations
Overview
Mutations
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Mechanism of Cardiac Arrhythmias
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Dysrhythmias II: Classification of Tachyarrhythmias
Tachyarrhythmias are a type of dysrhythmia where the heart rate exceeds 100 beats per minute. Here are some common types of tachyarrhythmias:Sinus TachycardiaSinus tachycardia originates from increased impulses from the sinus node, leading to an elevated heart rate. It is often triggered by stress, fever, or exercise.Patients may experience palpitations, a sensation of a racing heart, dizziness, and chest discomfort.Causes and Risk Factors: Common causes include physical exertion, emotional...

